Literature DB >> 2287541

Subacute necrotizing encephalomyelopathy (Leigh disease): CT and MRI appearances.

S B Greenberg1, E N Faerber, J J Riviello, G de Leon, M A Capitanio.   

Abstract

Subacute necrotizing encephalomyelopathy (SNE) is a genetic disorder of pyruvate metabolism. Until recently the diagnosis of SNE could only be made at autopsy. However, an antemortem diagnosis can now be suggested by the correlation of clinical and laboratory data with computed tomography (CT) and/or magnetic resonance imaging (MRI). Five children with clinical and laboratory data suggesting the diagnosis of Leigh disease were evaluated by CT and MR. MR was found to be more sensitive than CT in the detection of areas of necrosis in the brain of the five children we studied. The absence of focal lesions detected by either modality in one of our patients did not exclude the diagnosis of SNE since focal lesions were present at autopsy one month following CT and MR.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2287541     DOI: 10.1007/bf02010803

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  14 in total

1.  A unitary theory of causation of anoxic and hypoxic brain pathology.

Authors:  R E Myers
Journal:  Adv Neurol       Date:  1979

2.  Chronic relapsing course of encephalomyeloradiculopathy in a 6-year-old boy.

Authors:  R Riikonen; M Donner
Journal:  Neuropediatrics       Date:  1987-11       Impact factor: 1.947

3.  Comparative appraisal of CT scan and MRI in the diagnosis of Leigh encephalomyelopathy in two siblings.

Authors:  A Onuma; S Miyabayashi; K Iinuma; K Tada; K Yamada; T Matsuzawa
Journal:  J Child Neurol       Date:  1987-10       Impact factor: 1.987

Review 4.  Leigh syndrome, a mitochondrial encephalo(myo)pathy. A review of the literature.

Authors:  P M van Erven; J P Cillessen; E M Eekhoff; F J Gabreëls; W H Doesburg; W A Lemmens; J L Slooff; W O Renier; W Ruitenbeek
Journal:  Clin Neurol Neurosurg       Date:  1987       Impact factor: 1.876

5.  Adult form of Leigh's disease: a clinico pathological case with CT scan examination.

Authors:  F Gray; F Louarn; R Gherardi; J F Eizenbaum; C Marsault
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

6.  MR of Leigh's disease (subacute necrotizing encephalomyelopathy).

Authors:  P C Davis; J C Hoffman; I F Braun; P Ahmann; N Krawiecki
Journal:  AJNR Am J Neuroradiol       Date:  1987 Jan-Feb       Impact factor: 3.825

7.  Leigh disease: value of CT in presymptomatic patients and variability of the lesions with time.

Authors:  A Taccone; M Di Rocco; P Fondelli; F Cottafava
Journal:  J Comput Assist Tomogr       Date:  1989 Mar-Apr       Impact factor: 1.826

8.  Leigh's subacute necrotizing encephalomyelopathy: possible diagnosis by CT scan.

Authors:  J G Chi; H W Yoo; K H Chang; C W Kim; H R Moon; K W Ko
Journal:  Neuroradiology       Date:  1981       Impact factor: 2.804

9.  Variability of serial CT scans in subacute necrotizing encephalomyelopathy (Leigh disease).

Authors:  T K Koch; W D Lo; B O Berg
Journal:  Pediatr Neurol       Date:  1985 Jan-Feb       Impact factor: 3.372

10.  Magnetic resonance imaging in subacute necrotizing encephalomyelopathy (Leigh's disease).

Authors:  T K Koch; M H Yee; H T Hutchinson; B O Berg
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

View more
  3 in total

1.  Leigh syndrome in a 3-year-old boy with unusual brain MR imaging and pathologic findings.

Authors:  M Topçu; I Saatci; R A Apak; F Söylemezoglu; Z Akçören
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Acute bilateral striatal necrosis in an infant: CT and MRI.

Authors:  M T Sola Martínez; L Pierot; G Noseda; N Martin-Duverneuil; J P Harpey; C Roy; J Chiras
Journal:  Neuroradiology       Date:  1994-04       Impact factor: 2.804

3.  Leigh syndrome: serial MR imaging and clinical follow-up.

Authors:  J Arii; Y Tanabe
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.